Immortal time bias
|
|
2
|
432
|
October 29, 2023
|
Mixed models modelling
|
|
14
|
1146
|
October 26, 2023
|
Repeat cross sectional survey analysis in STATA - two time points
|
|
0
|
330
|
October 19, 2023
|
95% CIs of Sen, Sp, PPV, NPV, and AUROC curve
|
|
2
|
565
|
October 13, 2023
|
High relationship between variables in different phenotypes
|
|
0
|
265
|
October 13, 2023
|
Survival analysis for a disease vs non-disease cohort
|
|
2
|
308
|
October 5, 2023
|
Best Causal Inference method for repeated Cross-section Design
|
|
1
|
488
|
October 5, 2023
|
Log-transformation versus nonlinear regression in allometry
|
|
2
|
456
|
October 4, 2023
|
Use of ratios as dependent and independent variables in regression
|
|
0
|
472
|
October 4, 2023
|
RMS Causal Inference
|
|
51
|
19629
|
October 3, 2023
|
Flexible modeling of categorical variables
|
|
4
|
348
|
October 3, 2023
|
Creating composite variables with partial missing values
|
|
0
|
386
|
September 29, 2023
|
Relationship between statistical models and machine learning algorithms
|
|
4
|
1076
|
September 17, 2023
|
Hmisc::summaryM() table without lines between rows
|
|
1
|
526
|
September 9, 2023
|
Mathematical coupling in epidemiology
|
|
4
|
508
|
September 7, 2023
|
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups?
|
|
2
|
575
|
September 4, 2023
|
Why not use the inverse logit transformation to get fitted risks (probabilities) in epi?
|
|
10
|
6689
|
December 30, 2020
|
Development of prediction models for multi-omic data: Is this a valid approach to follow?
|
|
5
|
485
|
September 1, 2023
|
Comparison of Poisson regression models with same counting outcomes but 2 different scores as predictor
|
|
3
|
322
|
August 30, 2023
|
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models
|
|
4
|
671
|
August 29, 2023
|
Modelling outcome data with a limit of detection. Is a hurdle model appropriate?
|
|
18
|
6227
|
August 27, 2023
|
Post hoc test following Fisher's exact test
|
|
2
|
769
|
August 26, 2023
|
Effect modification in series of n-of-1 trials (repeated crossover)
|
|
2
|
445
|
August 25, 2023
|
ROC has a S shape, why?
|
|
30
|
3575
|
August 25, 2023
|
Seeking advice on estimating casual effects of multiple overlapping interventions with observational data
|
|
1
|
422
|
August 22, 2023
|
Should one derive risk difference from the odds ratio?
|
|
618
|
53581
|
August 16, 2023
|
How to handle multiple tests per patient in the development of diagnostic prediction model?
|
|
2
|
551
|
August 15, 2023
|
Time-to-event analysis with a blocking factor
|
|
3
|
546
|
August 14, 2023
|
Survival analysis vs. nested case-control analysis
|
|
3
|
879
|
August 14, 2023
|
External validation or a bigger modelling sample?
|
|
9
|
999
|
August 12, 2023
|